UJI SENSITIVITAS ANTIBIOTIKA TERHADAP BAKTERI PENYEBAB INFEKSI PADA LUKA PASCA OPERASI
Main Article Content
Abstract
Nosocomial infection is a systemic or local condition caused by a reaction to an infectious agent such as bacteria that occurs more than 48 hours after the patient is admitted to the hospital. One of the nosocomial infections is post-surgery wound infection which is a common problem that causes morbidity and mortality in hospitals. The challenge for doctors who treat infected patients is the accuracy of antibiotic therapy, which slows down the healing process of infection in postoperative wounds. This study aims to determine the sensitivity of antibiotics to bacteria that cause infections in post-surgery patient wounds which can be recommended as definitive therapy. This study is a retrospective cohort conducted descriptively during October 2020 with a total of 75 samples. The results of the study showed that antibiotic sensitivity to gram-negative bacteria was amikacin (91%), meropenem (81%), gentamycin (56%), ciprofloxacin (42%), cefepime (39%), cefoperazone sulbactam (39%), cotrimoxazole (28%), ceftazidime 25%, aztreonam (18%), ceftriaxone (14%), ampicillin-sulbactam (11%) and ampicillin (2%). Meanwhile, sensitivity to gram-positive bacteria is vancomycin (83%), linezolid (61%), gentamycin (61%), clindamycin (39%), erythomycin (39%), levofloxacin (33%), ciprofloxacin (28%), cotrimoxazole (22%) and ampicillin, cefotaxime, ceftazidime, ceftriaxone (17%), respectively. Antibiotics with a sensitivity of >80% that can be recommended as definitive therapy for post-operative wound infections are amikacin (91%) and meropenem (81%) for gram-negative bacteria and vancomycin (83%) for gram-positive bacteria.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- That its publication has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Edition. Elsevier.
Bush, K., & Bradford P.A. 2016. β-Lactams and β-Lactamase Inhibitors: An
Overview. Cold Spring Harb Perspect Med, 6(8), a025247.
Centers for Disease Control and Prevention. 2022. Antimicrobial Resistance.
Centers for Disease Control and Prevention, National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID). Division of
Healthcare Quality Promotion (DHQP).
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI
supplement M100. Clinical and Laboratory Standards Institute; 2020.
Khan, H.A., KanwalBaig, F., & Mehbook, R. 2017. Nosocomial infections:
Epidemiology, prevention, control and surveillance. Asian Pacific Journal
of Tropical Biomedicine, 7(5), 478-482.
Khanam, R.A., Islam, M.R., Sharif, A., Parveen, R., Sharmin, I., & Yusuf, M.A. 2018.
Bacteriological Profiles of Pus with Antimicrobial Sensitivity Pattern at a
Teaching Hospital in Dhaka City. Bangladesh Journal of Infectious
Diseases, 5(1), 10-14.
Larry MB. 2020. Escherichia coli Infections. Schmidt College of Medicine, Florida
Atlantic University dalam : https://www.msdmanuals.com diakses pada
12 Oktober 2020.
Le, T., Wang, L., Zeng, C., Fu, L., Liu, Z., & Hu, J. (2021). Clinical and
microbiological characteristics of nosocomial, healthcare-associated, and
community acquired Klebsiellapneumoniae infections in Guangzhou,
China. Antimicrob Resist Infect Control, 10(41), 2-11.
Lumentut, B.A. 2016. Isolasi dan Identifikasi Bakteri Aerob yang Berpotensi
Menyebabkan Infeksi Nosokomial di Irian E RSUP Prof. DR. R. D.
Kandou Manado. Universitas Sam Ratulangi Manado.
Mahat, P., Manandhar, S., & Baidya, B. 2017. Bacteriological Profile of Wound
Infection and Antibiotic Susceptibility Pattern of the Isolates. Journal of
Microbiology & Experimentation, 4(5), 1-8.
Negara, K.S. 2014. Analisis Implementasi Kebijakan Penggunaan Antibiotika
Rasional Untuk Mencegah Resistensi Antibiotika di RSUP Sanglah
Denpasar: Studi Kasus Infeksi Methicillin Resistant Staphylococcus
aureus, Jurnal Administrasi Kebijakan Kesehatan, 1(1), 42-50.
Perhimpunan Rumah Sakit Seluruh Indonesia (PERSI). (2020). Pelatihan Dokter Pencegah dan Pengendali Infeksi (Pelatihan IPCD). Tersedia dalam URL : https://persi.or.id/pelatihan-dokter-pencegah-dan-pengendali-infeksi-ipcd/. Diakses pada tanggal 23 Agustus 2021.
Pulido-Cejudo, A., Guzmán-Gutierrez, M., Jalife-Montaño, A., Ortiz-Covarrubias, A.,
Martínez-Ordaz, J.L., Noyola-Villalobos, H.F., & Hurtado-López, L.M. (2017).
Management of acute bacterial skin and skin structure infections with a focus on
patients at high risk of treatment failure. Therapeutic Advances in Infectious
Disease, 4(5), 143 –161
Rahman, M.S., Hasan, K., Ul-Banna. H., Raza, A.M., & Habibullah, T. (2019). A study on the initial outcome of selective non-operative management in penetrating abdominal injury in a tertiary care hospital in Bangladesh. Turk J Surg, 35(2), 117-123.
Sizar, O. Rahman, S., and Sundareshan, V. 2022. Amikacin. StatPearls
Sjamsuhidayat., & Dejong. (2014). Buku ajar Ilmu Bedah. Jakarta: Penerbit Buku
Kedokteran EGC.
Sugianli, A.K., Ginting, F., Kusumawati, R.L., Pranggono, E.H., Pasaribu, A.P.,
Gronthoud, F., Greelings, S., Parwati, I., Jong, M.D.D., Leth, F.V., and Schultsz,
C. (2017). Antimicrobial resistance in uropathogens and appropriateness of
empirical treatment: a population-based surveillance study in Indonesia. J
Antimicrob Chemother, 72(5), 1469–1477
Trojan, R., Razdan, L., & Singh, N. (2016). Antibiotic Susceptibility Patterns of Bacterial
Isolates from Pus Samples in a Tertiary Care Hospital of Punjab, India.
International Journal of Microbiology, 1, 1-4.